PT - JOURNAL ARTICLE AU - Codden, Christina J. AU - Larson, Amy AU - Awata, Junya AU - Perera, Gayani AU - Chin, Michael T. TI - Single nucleus RNA-sequencing reveals altered intercellular communication and dendritic cell activation in nonobstructive hypertrophic cardiomyopathy AID - 10.1101/2021.12.20.21267954 DP - 2022 Jan 01 TA - medRxiv PG - 2021.12.20.21267954 4099 - http://medrxiv.org/content/early/2022/01/05/2021.12.20.21267954.short 4100 - http://medrxiv.org/content/early/2022/01/05/2021.12.20.21267954.full AB - End stage, nonobstructive hypertrophic cardiomyopathy (HCM) is an intractable condition with no disease-specific therapies. To gain insights into the pathogenesis of nonobstructive HCM, we performed single nucleus RNA-sequencing (snRNA-seq) on human HCM hearts explanted at the time of cardiac transplantation and organ donor hearts serving as controls. Differential gene expression analysis revealed 64 differentially expressed genes linked to specific cell types and molecular functions. Analysis of ligand-receptor pair gene expression to delineate potential intercellular communication revealed significant reductions in expressed ligand-receptor pairs affecting the extracellular matrix, growth factor binding, peptidase regulator activity, platelet-derived growth factor binding and protease binding in the HCM tissue. Changes in Integrin-β1 receptor expression were responsible for many changes related to extracellular matrix interactions, by increasing in dendritic, smooth muscle and pericyte cells while decreasing in endothelial and fibroblast cells, suggesting potential mechanisms for fibrosis and microvascular disease in HCM and a potential role for dendritic cells. In contrast, there was an increase in ligand-receptor pair expression associated with adenylate cyclase binding, calcium channel molecular functions, channel inhibitor activity, ion channel inhibitor activity, phosphatase activator activity, protein kinase activator activity and titin binding, suggesting important shifts in various signaling cascades in nonobstructive, end stage HCM.Brief summary End stage, nonobstructive human HCM is associated with altered intercellular communication and dendritic cell activation, providing novel insights into potential disease mechanisms.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by American Heart Association Innovative Project Award 18IPA34170294 (MTC) National Center for Advancing Translational Sciences, National Institutes of Health, Award Number UL1TR002544 (MTC) National Heart, Lung, and Blood Institute of the National Institutes of Health, Award Number F32HL147492 (AL) Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB of Tufts Medical Center gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online in the Gene Expression Omnibus database under accession numbers GSE161921 and GSE181764 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=gse181764 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi